Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uroncological Group. [electronic resource]
Producer: 20150707Description: 232-9 p. digitalISSN:- 1873-7560
- Adenocarcinoma -- blood
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cyproterone Acetate -- administration & dosage
- Disease Progression
- Europe
- Humans
- Male
- Middle Aged
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Quality of Life
- Sexuality
- Survival Rate
- Time Factors
- Triptorelin Pamoate -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.